# Bausch Health Companies Inc. – FDA Inspection, Apr 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/bausch-health-companies-inc/1370a46a-7475-4bc7-aeec-1a1d3c8cf563
Source feed: FDA_Inspections

> FDA inspection 1089615 of Bausch Health Companies Inc., April 26, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1089615
- Company Name: Bausch Health Companies Inc.
- Inspection Date: 2019-04-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 2

## Related Documents

- FDA Inspection 1229765 - 2024-01-19
- FDA Inspection 1190487 - 2022-09-29
- [FDA Inspection 1108379 - 2019-09-19](https://www.keypedia.com/records/fda_inspections/bausch-health-companies-inc/e2abd951-f3e0-411f-b024-d327f2749e14)
- FDA Inspection 1007199 - 2017-02-17
- [FDA Inspection 914426 - 2015-02-20](https://www.keypedia.com/records/fda_inspections/bausch-health-companies-inc/9fabced7-0287-4c9b-ad69-2c72fef6ff40)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/ucheabuchi-c-chudi-nwankwor/18b01d08-3cfd-4ace-97b2-5f54b6427661)

Company: https://www.keypedia.com/companies/bausch-health-companies-inc/3ad20d84-706c-4643-9588-53b1986c23f5

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
